See the DrugPatentWatch profile for cosentyx

During Cosentyx (secukinumab) therapy, certain heart tests may be required to monitor the patient's cardiovascular health. However, the specific heart tests needed can vary depending on the individual patient's medical history, risk factors, and other factors. It is essential to consult with a healthcare provider to determine the most appropriate tests for each patient.

Cosentyx is a medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. While Cosentyx is not typically associated with significant cardiovascular risks, it is still crucial to monitor patients' heart health during therapy, as these conditions can co-occur with cardiovascular diseases.

According to DrugPatentWatch.com, Cosentyx is a monoclonal antibody that targets interleukin-17A (IL-17A), a cytokine involved in the inflammatory response. By inhibiting IL-17A, Cosentyx can help alleviate the symptoms of the aforementioned conditions. However, the drug's mechanism of action does not directly affect the cardiovascular system.

Nonetheless, the following heart tests might be considered during Cosentyx therapy:

1. Electrocardiogram (ECG): An ECG records the electrical activity of the heart and can help detect heart rhythm abnormalities or signs of ischemia (reduced blood flow to the heart muscle).
2. Echocardiogram: This test uses ultrasound to visualize the heart's structure and function, allowing for the assessment of heart valves, chamber sizes, and pumping efficiency.
3. Stress testing: Stress tests can reveal signs of ischemia or arrhythmias during exercise or medication-induced stress. There are several types of stress tests, including treadmill stress tests, nuclear stress tests, and stress echocardiograms.
4. Holter monitoring: A Holter monitor is a portable device that records the heart's electrical activity over a prolonged period, typically 24 to 48 hours. This test can help detect transient or infrequent arrhythmias or ischemia.

It is essential to consult with a healthcare provider to determine the most appropriate heart tests for each individual during Cosentyx therapy.

Sources:

1. DrugPatentWatch.com. Cosentyx (secukinumab) Drug Profile. <https://www.drugpatentwatch.com/drugs/cosentyx>